Terns Pharmaceuticals, Inc. (TERN)
42.91
-1.10
(-2.50%)
USD |
NASDAQ |
Dec 16, 16:00
42.96
+0.04
(+0.10%)
After-Hours: 20:00
Terns Pharmaceuticals Research and Development Expense (Annual): 70.11M for Dec. 31, 2024
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
| Johnson & Johnson | 17.26B |
| Eli Lilly & Co. | 10.99B |
| Altimmune, Inc. | 81.99M |
| Viking Therapeutics, Inc. | 101.64M |
| Rhythm Pharmaceuticals, Inc. | 237.25M |